Meniere disease

Goebel JA. 2015 Equilibrium Committee amendment to the 1995 AAO-HNS guidelines for the definition of Ménière's disease. Otolaryngol Head Neck Surg. 2016 Mar;154(3):403-4. Abstract

Basura GJ, Adams ME, Monfared A, et al. Clinical practice guideline: Ménière's disease. Otolaryngol Head Neck Surg. 2020 Apr;162(suppl 2):S1-55.Full text  Abstract

Lopez-Escamez JA, Carey J, Chung WH, et al; Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS); Korean Balance Society. Diagnostic criteria for Menière's disease. J Vestib Res. 2015;25(1):1-7.Full text  Abstract

American College of Radiology. ACR appropriateness criteria: hearing loss and/or vertigo. 2018 [internet publication].Full text

1. Goebel JA. 2015 Equilibrium Committee amendment to the 1995 AAO-HNS guidelines for the definition of Ménière's disease. Otolaryngol Head Neck Surg. 2016 Mar;154(3):403-4. Abstract

2. Thirlwall AS, Kundu S. Diuretics for Ménière's disease or syndrome. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD003599.Full text  Abstract

3. da Costa SS, de Sousa LC, Piza MR. Meniere's disease: overview, epidemiology, and natural history. Otolaryngol Clin North Am. 2002 Jun;35(3):455-95. Abstract

4. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg. 1995 Sep;113(3):181-5.

5. Wladislavosky-Waserman P, Facer GW, Mokri B, et al. Meniere's disease: a 30-year epidemiologic and clinical study in Rochester, MN, 1951-1980. Laryngoscope. 1984 Aug;94(8):1098-102. Abstract

6. Kim MH, Cheon C. Epidemiology and seasonal variation of Ménière's disease: data from a population-based study. Audiol Neurootol. 2020;25(4):224-30. Abstract

7. Paparella MM. Pathogenesis and pathophysiology of Meniere's disease. Acta Otolaryngol Suppl. 1991;111(suppl 485):26-35. Abstract

8. Zhang S, Guo Z, Tian E, et al. Meniere disease subtyping: the direction of diagnosis and treatment in the future. Expert Rev Neurother. 2022 Feb;22(2):115-27.Full text  Abstract

9. Huppert D, Strupp M, Brandt T. Long-term course of Menière's disease revisited. Acta Otolaryngol. 2010 Jun;130(6):644-51. Abstract

10. Morita Y, Takahashi K, Ohshima S, et al. Is vestibular Meniere's disease associated with endolymphatic hydrops? Front Surg. 2020 Dec 18:7:601692.Full text  Abstract

11. Lee CS, Paparella MM, Margolis RH, et al. Audiological profiles and Menière's disease. Ear Nose Throat J. 1995 Aug;74(8):527-32. Abstract

12. Conlon BJ, Gibson WP. Meniere's disease: the incidence of hydrops in the contralateral asymptomatic ear. Laryngoscope. 1999 Nov;109(11):1800-2. Abstract

13. Pulec L, House WF. Meniere's disease study: three-year progress report. Int J Equilib Res. 1973 Jun;3(1):156-65. Abstract

14. Pulec JL. Meniere's disease. Etiology, natural history, and results of treatment. Otolaryngol Clin North Am. 1973 Feb;6(1):25-39. Abstract

15. Paparella MM, Djalilian HR. Etiology, pathophysiology of symptoms, and pathogenesis of Meniere's disease. Otolaryngol Clin North Am. 2002 Jun;35(3):529-45, vi. Abstract

16. Merchant SN, Adams JC, Nadol JB Jr. Pathophysiology of Meniere's syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol. 2005 Jan;26(1):74-81. Abstract

17. Gürkov R, Pyykö I, Zou J, et al. What is Menière's disease? A contemporary re-evaluation of endolymphatic hydrops. J Neurol. 2016 Apr 15;263(suppl 1):S71-81.Full text  Abstract

18. Paparella MM, Fina M. Endolymphatic sac enhancement: reversal of pathogenesis. Otolaryngol Clin North Am. 2002 Jun;35(3):621-37. Abstract

19. Selmani Z, Marttila T, Pyykko I. Incidence of virus infection as a cause of Meniere's disease or endolymphatic hydrops assessed by electrocochleography. Eur Arch Otorhinolaryngol. 2005 Apr;262(4):331-4. Abstract

20. de Sousa LC, Piza MR, da Costa SS. Diagnosis of Meniere's disease: routine and extended tests. Otolaryngol Clin North Am. 2002 Jun;35(3):547-64. Abstract

21. Basura GJ, Adams ME, Monfared A, et al. Clinical practice guideline: Ménière's disease. Otolaryngol Head Neck Surg. 2020 Apr;162(suppl 2):S1-55.Full text  Abstract

22. Grant IL, Welling DB. The treatment of hearing loss in Meniere's disease. Otolaryngol Clin North Am. 1997 Dec;30(6):1123-44. Abstract

23. Ballester M, Liard P, Vibert D, et al. Meniere's disease in the elderly. Otol Neurotol. 2002 Jan;23(1):73-8. Abstract

24. Kentala E, Havia M, Pyykko I. Short-lasting drop attacks in Meniere's disease. Otolaryngol Head Neck Surg. 2001 May;124(5):526-30. Abstract

25. Gibson WP, Moffat DA, Ramsden RT. Clinical electrocochleography in the diagnosis and management of Menière's disorder. Audiology. 1977 Sep-Oct;16(5):389-401. Abstract

26. Ferraro JA, Durrant JD. Electrocochleography in the evaluation of patients with Ménière's disease/endolymphatic hydrops. J Am Acad Audiol. 2006 Jan;17(1):45-68. Abstract

27. Conlon BJ, Gibson WP. Electrocochleography in the diagnosis of Meniere's disease. Acta Otolaryngol. 2000 Jun;120(4):480-3. Abstract

28. Al-momani MO, Ferraro JA, Gajewski BJ, et al. Improved sensitivity of electrocochleography in the diagnosis of Meniere's disease. Int J Audiol. 2009 Nov;48(11):811-9. Abstract

29. Ferraro JA. Electrocochleography: a review of recording approaches, clinical applications, and new findings in adults and children. J Am Acad Audiol. 2010 Mar;21(3):145-52. Abstract

30. Ferraro J. Electrocochleography. In: Ross JR, Valente M, Hosford-Dunn H, eds. Audiologic diagnosis. 2nd ed. New York, NY: Thieme; 2000:425-50.

31. Xiao H, Guo X, Cai H, et al. Magnetic resonance imaging of endolymphatic hydrops in Ménière's disease: a comparison of the diagnostic value of multiple scoring methods. Front Neurol. 2022 Sep 26:13:967323.Full text  Abstract

32. Gürkov R, Flatz W, Louza J, et al. In vivo visualization of endolymphatic hydrops in patients with Meniere's disease: correlation with audiovestibular function. Eur Arch Otorhinolaryngol. 2011 Dec;268(12):1743-8. Abstract

33. Sano R, Teranishi M, Yamazaki M, et al. Contrast enhancement of the inner ear in magnetic resonance images taken at 10 minutes or 4 hours after intravenous gadolinium injection. Acta Otolaryngol. 2012 Mar;132(3):241-6. Abstract

34. Liu Y, Pyykkö I, Naganawa S, et al. Consensus on MR imaging of endolymphatic hydrops in patients with suspected hydropic ear disease (Meniere). Front Surg. 2022 Apr 28:9:874971.Full text  Abstract

35. Agrup C, Luxon LM. Immune-mediated inner-ear disorders in neuro-otology. Curr Opin Neurol. 2006 Feb;19(1):26-32. Abstract

36. Jerger J, Jerger S. Diagnostic significance of PB word functions. Arch Otolaryngol. 1971 Jun;93(6):573-80. Abstract

37. Fetterman BL. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops. Laryngoscope. 2001 Jun;111(6):946-54. Abstract

38. Young YH, Huang TW, Cheng PW. Assessing the stage of Meniere's disease using vestibular evoked myogenic potentials. Arch Otolaryngol Head Neck Surg. 2003 Aug;129(8):815-8. Abstract

39. Kentala E, Pyykkö I. Vestibular schwannoma mimicking Ménière's disease. Acta Otolaryngol Suppl. 2000;120(suppl 543):17-9. Abstract

40. Shepard NT. Differentiation of Ménière's disease and migraine-associated dizziness: a review. J Am Acad Audiol. 2006 Jan;17(1):69-80. Abstract

41. Roland PS, Marple BF, Meyerhoff WL, eds. Hearing loss. New York, NY: Thieme Medical Publishers, Inc.; 1997.

42. Karlberg M, Hall K, Quickert N, et al. What inner ear diseases cause benign paroxysmal positional vertigo? Acta Otolaryngol. 2000 Mar;120(3):380-5. Abstract

43. Bhattacharyya N, Gubbels SP, Schwartz SR, et al. Clinical practice guideline: benign paroxysmal positional vertigo (update). Otolaryngol Head Neck Surg. 2017 Mar;156(3 suppl):S1-47.Full text  Abstract

44. Baloh RW. The dizzy patient. Postgrad Med. 1999 Feb;105(2):161-4, 167-72. Abstract

45. Lopez-Escamez JA, Carey J, Chung WH, et al; Classification Committee of the Barany Society; Japan Society for Equilibrium Research; European Academy of Otology and Neurotology (EAONO); Equilibrium Committee of the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS); Korean Balance Society. Diagnostic criteria for Menière's disease. J Vestib Res. 2015;25(1):1-7.Full text  Abstract

46. Chandrasekhar SS, Tsai Do BS, Schwartz SR, et al. Clinical practice guideline: sudden hearing loss (update). Otolaryngol Head Neck Surg. 2019 Aug;161(suppl 1):S1-45.Full text  Abstract

47. American College of Radiology. ACR appropriateness criteria: hearing loss and/or vertigo. 2018 [internet publication].Full text

48. Kinney SE, Sandridge SA, Newman CW. Long-term effects of Ménière's disease on hearing and quality of life. Am J Otol. 1997 Jan;18(1):67-73. Abstract

49. Hamill TA. Evaluating treatments for Ménière's disease: controversies surrounding placebo control. J Am Acad Audiol. 2006 Jan;17(1):27-37. Abstract

50. Gacek RR, Gacek MR. Menière's disease as a manifestation of vestibular ganglionitis. Am J Otolaryngol. 2001 Jul-Aug;22(4):241-50. Abstract

51. Rickenstein MJ, Harrison RV. Cochlear pathophysiology in Meniere’s disease: a critical appraisal. In: Harris JP, ed. Ménière’s disease. The Hague, Netherlands: Kugler Publications; 1999:195-202.

52. Colletti V. Medical treatment in Meniere's disease: avoiding vestibular neurectomy and facilitating postoperative compensation. Acta Otolaryngol Suppl. 2000;120(suppl 544):27-33. Abstract

53. Hussain K, Murdin L, Schilder AG. Restriction of salt, caffeine and alcohol intake for the treatment of Ménière's disease or syndrome. Cochrane Database Syst Rev. 2018 Dec 31;(12):CD012173.Full text  Abstract

54. Webster KE, George B, Lee A, et al. Lifestyle and dietary interventions for Ménière's disease. Cochrane Database Syst Rev. 2023 Feb 27;2(2):CD015244.Full text  Abstract

55. Webster KE, Galbraith K, Harrington-Benton NA, et al. Systemic pharmacological interventions for Ménière's disease. Cochrane Database Syst Rev. 2023 Feb 23;2(2):CD015171.Full text  Abstract

56. Nishiyama S, Okada T, Kobayashi T, et al. Na-K-ATPase activity in the guinea pig stria vascularis in experimentally-induced endolymphatic hydrops. Histol Histopathol. 1994 Apr;9(2):205-9. Abstract

57. Soto E, Vega R. Neuropharmacology of vestibular system disorders. Curr Neuropharmacol. 2010 Mar;8(1):26-40.Full text  Abstract

58. James AL, Burton MJ. Betahistine for Ménière's disease or syndrome. Cochrane Database Syst Rev. 2001 Jan 22;(1):CD001873.Full text  Abstract

59. Adrion C, Fischer CS, Wagner J, et al. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ. 2016 Jan 21;352:h6816.Full text  Abstract

60. Silverstein H, Isaacson JE, Olds MJ, et al. Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial. Am J Otol. 1998 Mar;19(2):196-201. Abstract

61. Newman CW, Weinstein BE, Jacobson GP, et al. The Hearing Handicap Inventory for Adults: psychometric adequacy and audiometric correlates. Ear Hear. 1990 Dec;11(6):430-3. Abstract

62. Newman CW, Jacobson GP, Spitzer JB. Development of the Tinnitus Handicap Inventory. Arch Otolaryngol Head Neck Surg. 1996 Feb;122(2):143-8. Abstract

63. Newman CW, Sandridge SA, Jacobson GP. Psychometric adequacy of the Tinnitus Handicap Inventory (THI) for evaluating treatment outcome. J Am Acad Audiol. 1998 Apr;9(2):153-60. Abstract

64. Jastreboff PJ, Hazell JW. A neurophysiological approach to tinnitus: clinical implications. Br J Audiol. 1993 Feb;27(1):7-17. Abstract

65. Jastreboff PJ, Hazell JW. Treatment of tinnitus based on a neurophysiological model. In: Vernon J, ed. Tinnitus: treatment and relief. Boston, MA: Allyn & Bacon; 1998:201-16.

66. Davis PB, Paki B, Hanley PJ. Neuromonics Tinnitus Treatment: third clinical trial. Ear Hear. 2007 Apr;28(2):242-59. Abstract

67. Hanley PJ, Davis PB, Paki B, et al. Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: clinical outcomes in general private practice. Ann Otol Rhinol Laryngol. 2008 Nov;117(11):791-9. Abstract

68. Davis PB, Wilde RA, Steed LG, et al. Treatment of tinnitus with a customized acoustic neural stimulus: a controlled clinical study. Ear Nose Throat J. 2008 Jun;87(6):330-9. Abstract

69. Johnson RM, Brummett R, Schleuning A. Use of alprazolam for relief of tinnitus. A double-blind study. Arch Otolaryngol Head Neck Surg. 1993 Aug;119(8):842-5. Abstract

70. Valente M, Mispagel K, Valente LM, et al. Problems and solutions for fitting amplification to patients with Meniere's disease. J Am Acad Audiol. 2006 Jan;17(1):6-15. Abstract

71. Patel M, Agarwal K, Arshad Q, et al. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial. Lancet. 2016 Dec 3;388(10061):2753-62.Full text  Abstract

72. Shea JJ, Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Ménière's disease. Otolaryngol Clin North Am. 1996 Apr;29(2):353-8. Abstract

73. Shea JJ. The role of dexamethasone or streptomycin perfusion in the treatment of Meniere's disease. Otolaryngol Clin North Am. 1997 Dec;30(6):1051-9. Abstract

74. Barrs DM, Keyser JS, Stallworth C, et al. Intratympanic steroid injections for intractable Ménière's disease. Laryngoscope. 2001 Dec;111(12):2100-4. Abstract

75. Chia SH, Gamst AC, Anderson JP, et al. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol. 2004 Jul;25(4):544-52. Abstract

76. Cohen-Kerem R, Kisilevsky V, Einarson TR, et al. Intratympanic gentamicin for Menière's disease: a meta-analysis. Laryngoscope. 2004 Dec;114(12):2085-91. Abstract

77. Postema RJ, Kingma CM, Wit HP, et al. Intratympanic gentamicin therapy for control of vertigo in unilateral Menière's disease: a prospective, double-blind, randomized, placebo-controlled trial. Acta Otolaryngol. 2008 Aug;128(8):876-80. Abstract

78. Webster KE, Lee A, Galbraith K, et al. Intratympanic corticosteroids for Ménière's disease. Cochrane Database Syst Rev. 2023 Feb 27;2(2):CD015245.Full text  Abstract

79. Webster KE, Galbraith K, Lee A, et al. Intratympanic gentamicin for Ménière's disease. Cochrane Database Syst Rev. 2023 Feb 27;2(2):CD015246.Full text  Abstract

80. Gates GA, Verrall A, Green JD Jr, et al. Meniett clinical trial: long-term follow-up. Arch Otolaryngol Head Neck Surg. 2006 Dec;132(12):1311-6.Full text  Abstract

81. Thomsen J, Sass K, Odkvist L, et al. Local overpressure treatment reduces vestibular symptoms in patients with Meniere's disease: a clinical, randomized, multicenter, double-blind, placebo-controlled study. Otol Neurotol. 2005 Jan;26(1):68-73. Abstract

82. van Sonsbeek S, Pullens B, van Benthem PP. Positive pressure therapy for Ménière's disease or syndrome. Cochrane Database Syst Rev. 2015 Mar 10;(3):CD008419.Full text  Abstract

83. Webster KE, George B, Galbraith K, et al. Positive pressure therapy for Ménière's disease. Cochrane Database Syst Rev. 2023 Feb 23;2(2):CD015248.Full text  Abstract

84. Bretlau P, Thomsen J, Tos M, et al. Placebo effect in surgery for Meniere's disease: nine-year follow-up. Am J Otol. 1989 Jul;10(4):259-61. Abstract

85. Pillsbury HC, Arenberg IK, Ferraro J, et al. Endolymphatic sac surgery. The Danish sham surgery study: an alternative analysis. Otolaryngol Clin North Am. 1983 Feb;16(1):123-7.

86. Thomsen J, Bretlau P, Tos M, et al. Ménière's disease: endolymphatic sac decompression compared with sham (placebo) decompression. Ann N Y Acad Sci. 1981 Nov;374(1):820-30. Abstract

87. Thomsen J, Bonding P, Becker B, et al. The non-specific effect of endolymphatic sac surgery in treatment of Meniere's disease: a prospective, randomized controlled study comparing "classic" endolymphatic sac surgery with the insertion of a ventilating tube in the tympanic membrane. Acta Otolaryngol. 1998 Nov;118(6):769-73. Abstract

88. Pullens B, Verschuur HP, van Benthem PP. Surgery for Ménière's disease. Cochrane Database Syst Rev. 2013 Feb 28;(2):CD005395.Full text  Abstract

89. Szott FA, Westhofen M, Hackenberg S. Is endolymphatic sac surgery an efficient treatment of Menière's disease patients? A systematic literature search and meta-analysis. Eur Arch Otorhinolaryngol. 2023 Mar;280(3):1119-28.Full text  Abstract

90. McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev. 2015 Jan 13;(1):CD005397.Full text  Abstract

91. Hansson EE. Vestibular rehabilitation: for whom and how? A systematic review. Adv Physiother. 2007;9(3):106-16.

92. Gottshall KR, Hoffer ME, Moore RJ, et al. The role of vestibular rehabilitation in the treatment of Meniere's disease. Otolaryngol Head Neck Surg. 2005 Sep;133(3):326-8. Abstract

93. Paparella MM, Sajjadi H. Endolymphatic sac enhancement. Principles of diagnosis and treatment. Am J Otol. 1987 Jul;8(4):294-300. Abstract

94. Silverstein H, Jackson LE. Vestibular nerve section. Otolaryngol Clin North Am. 2002 Jun;35(3):655-73. Abstract

95. Møller MN, Cayé-Tomasen P, Thomsen JH. Vestibular nerve section in the treatment of morbus Ménière [in Danish]. Ugeskr Laeger. 2009 Mar 16;171(12):1000-3. Abstract

96. Berryhill WE, Graham MD. Chemical and physical labyrinthectomy for Meniere's disease. Otolaryngol Clin North Am. 2002 Jun;35(3):675-82. Abstract

97. Graham MD, Colton JJ. Transmastoid labyrinthectomy indications. Technique and early postoperative results. Laryngoscope. 1980 Aug;90(8 Pt 1):1253-62. Abstract

98. Lustig LR, Yeagle J, Niparko JK, et al. Cochlear implantation in patients with bilateral Ménière's syndrome. Otol Neurotol. 2003 May;24(3):397-403. Abstract

99. Pothula VB, Chew F, Lesser TH, et al. Falls and vestibular impairment. Clin Otolaryngol Allied Sci. 2004 Apr;29(2):179-82. Abstract